329 related articles for article (PubMed ID: 21909266)
1. Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders.
Borjabad A; Morgello S; Chao W; Kim SY; Brooks AI; Murray J; Potash MJ; Volsky DJ
PLoS Pathog; 2011 Sep; 7(9):e1002213. PubMed ID: 21909266
[TBL] [Abstract][Full Text] [Related]
2. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.
Levine AJ; Miller JA; Shapshak P; Gelman B; Singer EJ; Hinkin CH; Commins D; Morgello S; Grant I; Horvath S
BMC Med Genomics; 2013 Feb; 6():4. PubMed ID: 23406646
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder.
Canchi S; Swinton MK; Rissman RA; Fields JA
J Neuroinflammation; 2020 Apr; 17(1):112. PubMed ID: 32276639
[TBL] [Abstract][Full Text] [Related]
4. Neuro-immune deconvolution analysis of OAS3 as a transcriptomic central node in HIV-associated neurocognitive disorders.
Sanfilippo C; Castrogiovanni P; Vinciguerra M; Imbesi R; Ulivieri M; Fazio F; Cantarella A; Nunnari G; Di Rosa M
J Neurol Sci; 2023 Mar; 446():120562. PubMed ID: 36706688
[TBL] [Abstract][Full Text] [Related]
5. OAS Gene Family Expression Is Associated with HIV-Related Neurocognitive Disorders.
Sanfilippo C; Pinzone MR; Cambria D; Longo A; Palumbo M; Di Marco R; Condorelli F; Nunnari G; Malaguarnera L; Di Rosa M
Mol Neurobiol; 2018 Mar; 55(3):1905-1914. PubMed ID: 28236279
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.
Rubin LH; Saylor D; Nakigozi G; Nakasujja N; Robertson K; Kisakye A; Batte J; Mayanja R; Anok A; Lofgren SM; Boulware DR; Dastgheyb R; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Sacktor N
J Neurovirol; 2019 Dec; 25(6):800-813. PubMed ID: 31218522
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy.
Wu JQ; Sassé TR; Saksena MM; Saksena NK
Virol J; 2013 Dec; 10():361. PubMed ID: 24370116
[TBL] [Abstract][Full Text] [Related]
8. Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related.
Falasca K; Reale M; Ucciferri C; Di Nicola M; Di Martino G; D'Angelo C; Coladonato S; Vecchiet J
AIDS Res Hum Retroviruses; 2017 Mar; 33(3):246-253. PubMed ID: 27615271
[TBL] [Abstract][Full Text] [Related]
9. HIV Nef and Antiretroviral Therapy Have an Inhibitory Effect on Autophagy in Human Astrocytes that May Contribute to HIV-Associated Neurocognitive Disorders.
Cheney L; Guzik H; Macaluso FP; Macian F; Cuervo AM; Berman JW
Cells; 2020 Jun; 9(6):. PubMed ID: 32526847
[TBL] [Abstract][Full Text] [Related]
10. When do models of NeuroAIDS faithfully imitate "the real thing"?
Gelman BB; Endsley J; Kolson D
J Neurovirol; 2018 Apr; 24(2):146-155. PubMed ID: 29256039
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy.
Mbugua KK; Holmes MJ; Cotton MF; Ratai EM; Little F; Hess AT; Dobbels E; Van der Kouwe AJ; Laughton B; Meintjes EM
AIDS; 2016 Jun; 30(9):1353-62. PubMed ID: 26959509
[TBL] [Abstract][Full Text] [Related]
12. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders.
Giunta B; Ehrhart J; Obregon DF; Lam L; Le L; Jin J; Fernandez F; Tan J; Shytle RD
Mol Brain; 2011 Jun; 4(1):23. PubMed ID: 21649911
[TBL] [Abstract][Full Text] [Related]
14. Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.
Borjabad A; Volsky DJ
J Neuroimmune Pharmacol; 2012 Dec; 7(4):914-26. PubMed ID: 23065460
[TBL] [Abstract][Full Text] [Related]
15. PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.
Vera JH; Ridha B; Gilleece Y; Amlani A; Thorburn P; Dizdarevic S
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):895-902. PubMed ID: 28058461
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
Cassol E; Misra V; Dutta A; Morgello S; Gabuzda D
AIDS; 2014 Jul; 28(11):1579-91. PubMed ID: 24752083
[TBL] [Abstract][Full Text] [Related]
17. The HIV Restriction Factor Profile in the Brain Is Associated with the Clinical Status and Viral Quantities.
Mohammadzadeh N; Zhang N; Branton WG; Zghidi-Abouzid O; Cohen EA; Gelman BB; Estaquier J; Kong L; Power C
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851531
[TBL] [Abstract][Full Text] [Related]
18. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
[TBL] [Abstract][Full Text] [Related]
19. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
[TBL] [Abstract][Full Text] [Related]
20. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
